Antibody Response 3 Months After 2-Dose SARS-CoV-2 mRNA Vaccination in Patients With Inflammatory Bowel Disease
Evangelos Tsipotis(Johns Hopkins University), Mark Lazarev(Johns Hopkins University), Florin M. Selaru(Sidney Kimmel Cancer Center), Sharon Dudley‐Brown(Johns Hopkins University), Dorry L. Segev(New York University), William A. Werbel(Johns Hopkins University), Alyssa Parian(Johns Hopkins University), Joanna Melia(Johns Hopkins University), Sarah Frey(Johns Hopkins University), Reezwana Chowdhury(Johns Hopkins University), Brindusa Truta, Huimin Yu(Johns Hopkins University), Caoilfhionn M Connolly
Cited by 7
Related Papers
Foot strike patterns and collision forces in habitually barefoot versus shod runners
|Nature|2010|1.4k
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
|American Journal of Transplantation|2017|1k
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
|JAMA|2021|1k